CIK 0000820318 · Large accelerated filer
COHERENT CORP.
Sign in to watch- Ticker
- COHR
- Exchange
- NYSE
- Industry
- Optical Instruments & Lenses
- FY end
- Jun 30
- Incorporated
- PA
- Entity type
- operating
- EIN
- 251214948
- Phone
- 724-352-4455
- Business address
- 375 SAXONBURG BLVD, SAXONBURG, PA, 16056
- Former names
- II-VI INC
- Open-market buys, last 90 days
- $1,220,285
- in 2 filings
- Open-market sales, last 90 days
- $8,184,635
- in 7 filings, $5.8M under 10b5-1 plans
Net −$6,964,350. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-12-16 | Koeppen Christopher Chief Innovation Officer | Sale 10b5-1 | −2,916 | $108.84 | $317K | 55,338 |
| 2024-12-04 | Xia Howard H. Director | Option exercise | +2,000 | $17.84 | $36K | 49,747 |
| 2024-12-04 | Xia Howard H. Director | Sale | −1,000 | $109.45 | $109K | 48,747 |
| 2024-12-04 | Xia Howard H. Director | Sale | −1,000 | $112.00 | $112K | 47,747 |
| 2024-12-04 | Xia Howard H. Director | Option exercise · Option (Right to buy) | −2,000 | 6,000 | ||
| 2024-12-03 | Koeppen Christopher Chief Innovation Officer | Sale 10b5-1 | −2,590 | $107.00 | $277K | 60,502 |
| 2024-12-03 | Xia Howard H. Director | Option exercise | +970 | $17.84 | $17K | 48,717 |
| 2024-12-03 | Xia Howard H. Director | Sale | −970 | $106.00 | $103K | 47,747 |
| 2024-12-03 | Xia Howard H. Director | Option exercise · Option (Right to buy) | −970 | 8,000 | ||
| 2024-12-02 | ANDERSON JAMES ROBERT CEO & President | Purchase | +500 | $102.72 | $51K | 149,214 |
| 2024-11-28 | Mocciaro Ilaria SVP, CAO & Corp. Controller | Grant or award | +7,647 | 22,979 | ||
| 2024-11-26 | CORASANTI JOSEPH J Director | Option exercise | +9,240 | $21.67 | $200K | 101,882 |
| 2024-11-26 | CORASANTI JOSEPH J Director | Sale | −9,240 | $101.29 | $936K | 92,642 |
| 2024-11-26 | CORASANTI JOSEPH J Director | Option exercise · Option (Right to Buy) | −9,240 | 0 | ||
| 2024-11-22 | Koeppen Christopher Chief Innovation Officer | Sale 10b5-1 | −2,248 | $105.00 | $236K | 58,254 |
| 2024-11-22 | ANDERSON JAMES ROBERT CEO & President | Purchase | +500 | $103.98 | $52K | 148,714 |
| 2024-11-15 | Koeppen Christopher Chief Innovation Officer | Sale 10b5-1 | −400 | $92.87 | $37K | 64,692 |
| 2024-11-15 | Koeppen Christopher Chief Innovation Officer | Sale 10b5-1 | −500 | $94.19 | $47K | 64,192 |
| 2024-11-15 | Koeppen Christopher Chief Innovation Officer | Sale 10b5-1 | −692 | $95.28 | $66K | 63,500 |
| 2024-11-15 | Koeppen Christopher Chief Innovation Officer | Sale 10b5-1 | −308 | $96.73 | $30K | 63,192 |
Page 10 of 73 · 1,443 trades